Beijing PINS Medical Co., Ltd.

Changping, Beijing, ChinaFounded 2008101–250 employeespinsmedical.comLinkedIn

PINS Medical specializes in the research, development, production, and sales of neuromodulation products.

Visit pinsmedical.com ↗

Founded: 2008
Employees: 101–250

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Sep 2026

Recent highlights

As of Sep 29, 2026, PINS Medical’s available profile indicates an active neuromodulation-device business based in Changping, Beijing, with an employee band of approximately 101–250 people. The company’s current product coverage spans several clinically distinct stimulation categories: deep brain stimulation for neurological disorders, vagus nerve stimulation for drug-resistant epilepsy, sacral neuromodulation for overactive bladder, and spinal cord stimulation for chronic refractory pain. Its portfolio also includes patient programmers and test stimulators, suggesting participation in both implantable hardware and the supporting clinical workflow. Two product descriptions identify differentiated device capabilities: a deep brain stimulation system compatible with 3.0T MRI and the rechargeable, directional G107R deep brain stimulator.

Market position

PINS Medical operates in the medical-device segment of neuromodulation, a market that includes deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, and sacral nerve stimulation. Its stated scope is broader than a single-condition device company: the portfolio covers Parkinson’s disease and other neurological disorders, drug-resistant epilepsy, overactive bladder, and chronic pain. That breadth may provide opportunities to reuse engineering, manufacturing, programming, and clinical-support capabilities across indications. The 3.0T MRI-compatible deep brain stimulation system and rechargeable directional G107R device are notable product attributes because MRI access and directional stimulation address practical limitations associated with implanted neurostimulators. It therefore does not support a precise ranking against international specialists such as Medtronic, Abbott, Boston Scientific, or LivaNova. PINS Medical’s clearest observable differentiator is portfolio breadth within neuromodulation, combined with products spanning implants and external programming equipment; its competitive strength remains difficult to quantify without outcome, distribution, and revenue data.

Growth & opportunities

PINS Medical was founded in 2008 and is listed as active, with an employee range of 101–250. Its product portfolio indicates a progression from a core neuromodulation capability toward coverage of multiple stimulation modalities: deep brain, vagus nerve, sacral nerve, and spinal cord systems. The inclusion of a 3.0T MRI-compatible deep brain stimulation system and the rechargeable directional G107R suggests product development focused on compatibility, battery convenience, and more targeted stimulation. Patient programmers and test stimulators extend the offering beyond implanted components into clinical programming and device-management workflows. Consequently, the company’s trajectory can be characterized as portfolio expansion and sustained operation rather than quantified high-growth scaling. Further assessment would require dated commercialization milestones, geographic sales information, regulatory filings, clinical evidence, and evidence of workforce or capital expansion.

Written by reccy's AI from company sites, press and funding records · updated Sep 2026

Technology & products6

3.0T Magnetic Resonance Compatible Deep Brain Stimulation System
An implantable brain pacemaker system compatible with 3.0T MRI, providing electrical stimulation for neurological disorders like Parkinson's disease.
Rechargeable Directional Deep Brain Stimulator (G107R)
A rechargeable brain pacemaker with directional stimulation capability for precise targeting of brain regions in neurological therapy.
Implantable Vagus Nerve Stimulator (VNS) System
An implantable device that electrically stimulates the vagus nerve to treat drug-resistant epilepsy in patients aged three years and older.
Rechargeable Sacral Neuromodulation System
An implantable system providing electrical stimulation to sacral nerves to treat overactive bladder symptoms unresponsive to conservative treatments.
Implantable Spinal Cord Stimulator (SCS) System
An implantable device that delivers electrical stimulation to the spinal cord to assist in managing chronic refractory pain in the trunk and limbs.
Patient Programmers and Test Stimulators
External devices for patients and clinicians to program, test, and adjust implanted neuromodulation devices remotely or in clinical settings.

Show all 6 products

+ 3 more: Rechargeable Sacral Neuromodulation System, Implantable Spinal Cord Stimulator (SCS) System, Patient Programmers and Test Stimulators

About Beijing PINS Medical Co., Ltd.

Products: 3.0T Magnetic Resonance Compatible Deep Brain Stimulation System, Rechargeable Directional Deep Brain Stimulator (G107R), Implantable Vagus Nerve Stimulator (VNS) System, Rechargeable Sacral Neuromodulation System, Implantable Spinal Cord Stimulator (SCS) System, Patient Programmers and Test Stimulators
Focus areas: NeuroTechnology, neuromodulation, medical devices, healthcare, manufacturing
Headquarters: Changping, Beijing, China
Founded: 2008
Employees: 101–250